schliessen

Filtern

 

Bibliotheken

The evaluation ofefficacy and safety of Cough (EMA) granules used for upper respiratory disorders

Ivy leaf is used for the treatment of respiratory diseases with the intensive mucus formation, respiratory infections, and irritating cough coming from the common cold. Conferring to clinical trials, the efficacy, and tolerability of ivy leaf is good. The main compounds accountable for biological ac... Full description

Journal Title: Pakistan journal of pharmaceutical sciences November 2018, Vol.31(6 (Supplementary), pp.2617-2622
Main Author: Khan, Muhammad Faizan
Other Authors: Akram, Muhammad , Akhter, Naheed , Mukhtiar, Muhammad , Zahid, Rabia , Khan, Fahad Said , Daniyal, Muhammad , Tahir, Imtiaz Mahmood , Ahmed, Khalil , Sharif, Aamir , Kausar, Shamaila , Shah, Syed Muhammad Ali , Usmanghani, Khan
Format: Electronic Article Electronic Article
Language: English
Subjects:
ID: ISSN: 1011-601X ; PMID: 30587469 Version:1
Link: http://pubmed.gov/30587469
Zum Text:
SendSend as email Add to Book BagAdd to Book Bag
Staff View
recordid: medline30587469
title: The evaluation ofefficacy and safety of Cough (EMA) granules used for upper respiratory disorders
format: Article
creator:
  • Khan, Muhammad Faizan
  • Akram, Muhammad
  • Akhter, Naheed
  • Mukhtiar, Muhammad
  • Zahid, Rabia
  • Khan, Fahad Said
  • Daniyal, Muhammad
  • Tahir, Imtiaz Mahmood
  • Ahmed, Khalil
  • Sharif, Aamir
  • Kausar, Shamaila
  • Shah, Syed Muhammad Ali
  • Usmanghani, Khan
subjects:
  • Althaea
  • Hedera
  • Cough -- Drug Therapy
  • Plant Extracts -- Therapeutic Use
  • Respiratory Tract Infections -- Drug Therapy
ispartof: Pakistan journal of pharmaceutical sciences, November 2018, Vol.31(6 (Supplementary), pp.2617-2622
description: Ivy leaf is used for the treatment of respiratory diseases with the intensive mucus formation, respiratory infections, and irritating cough coming from the common cold. Conferring to clinical trials, the efficacy, and tolerability of ivy leaf is good. The main compounds accountable for biological activity are triterpene and saponins. Ivy leaves show convulsive/antispasmodic, anti-inflammatory, antimicrobial, analgesic, anthelmintic and anti-thrombin activity. Not only ivy but also marshmallow and mustard seeds are used for these indications. This study was conducted to evaluate the efficacy and safety of Cough (EMA; European Medicines Agency) granules used for upper respiratory disorders. This clinical trial was conducted on 150 patients, out of which 75received the Cough (EMA) granules and 75received the placebo. The age range of patients was 3 years to above 15 years. The sample paired t-test was applied to evaluate the significant level. Cough (EMA) granules were found effective in the treatment of cough, cold, and flu symptoms. The new treatment Cough (EMA) granules were safe and well tolerated in patient at given specific age group. The study recommends that Cough (EMA) granules can be used effectively in the treatment of upper respiratory tract infection.
language: eng
source:
identifier: ISSN: 1011-601X ; PMID: 30587469 Version:1
fulltext: fulltext
issn:
  • 1011601X
  • 1011-601X
url: Link


@attributes
ID508060759
RANK0.07
NO1
SEARCH_ENGINEprimo_central_multiple_fe
SEARCH_ENGINE_TYPEPrimo Central Search Engine
LOCALfalse
PrimoNMBib
record
control
sourcerecordid30587469
sourceidmedline
recordidTN_medline30587469
sourceformatXML
sourcesystemOther
pqid2161064640
galeid569606775
display
typearticle
titleThe evaluation ofefficacy and safety of Cough (EMA) granules used for upper respiratory disorders
creatorKhan, Muhammad Faizan ; Akram, Muhammad ; Akhter, Naheed ; Mukhtiar, Muhammad ; Zahid, Rabia ; Khan, Fahad Said ; Daniyal, Muhammad ; Tahir, Imtiaz Mahmood ; Ahmed, Khalil ; Sharif, Aamir ; Kausar, Shamaila ; Shah, Syed Muhammad Ali ; Usmanghani, Khan
ispartofPakistan journal of pharmaceutical sciences, November 2018, Vol.31(6 (Supplementary), pp.2617-2622
identifierISSN: 1011-601X ; PMID: 30587469 Version:1
subjectAlthaea ; Hedera ; Cough -- Drug Therapy ; Plant Extracts -- Therapeutic Use ; Respiratory Tract Infections -- Drug Therapy
descriptionIvy leaf is used for the treatment of respiratory diseases with the intensive mucus formation, respiratory infections, and irritating cough coming from the common cold. Conferring to clinical trials, the efficacy, and tolerability of ivy leaf is good. The main compounds accountable for biological activity are triterpene and saponins. Ivy leaves show convulsive/antispasmodic, anti-inflammatory, antimicrobial, analgesic, anthelmintic and anti-thrombin activity. Not only ivy but also marshmallow and mustard seeds are used for these indications. This study was conducted to evaluate the efficacy and safety of Cough (EMA; European Medicines Agency) granules used for upper respiratory disorders. This clinical trial was conducted on 150 patients, out of which 75received the Cough (EMA) granules and 75received the placebo. The age range of patients was 3 years to above 15 years. The sample paired t-test was applied to evaluate the significant level. Cough (EMA) granules were found effective in the treatment of cough, cold, and flu symptoms. The new treatment Cough (EMA) granules were safe and well tolerated in patient at given specific age group. The study recommends that Cough (EMA) granules can be used effectively in the treatment of upper respiratory tract infection.
languageeng
source
version3
lds50peer_reviewed
links
openurl$$Topenurl_article
backlink$$Uhttp://pubmed.gov/30587469$$EView_this_record_in_MEDLINE/PubMed
openurlfulltext$$Topenurlfull_article
addlink$$Uhttp://exlibris-pub.s3.amazonaws.com/aboutMedline.html$$EView_the_MEDLINE/PubMed_Copyright_Statement
search
creatorcontrib
0Khan, Muhammad Faizan
1Akram, Muhammad
2Akhter, Naheed
3Mukhtiar, Muhammad
4Zahid, Rabia
5Khan, Fahad Said
6Daniyal, Muhammad
7Tahir, Imtiaz Mahmood
8Ahmed, Khalil
9Sharif, Aamir
10Kausar, Shamaila
11Shah, Syed Muhammad Ali
12Usmanghani, Khan
titleThe evaluation ofefficacy and safety of Cough (EMA) granules used for upper respiratory disorders
descriptionIvy leaf is used for the treatment of respiratory diseases with the intensive mucus formation, respiratory infections, and irritating cough coming from the common cold. Conferring to clinical trials, the efficacy, and tolerability of ivy leaf is good. The main compounds accountable for biological activity are triterpene and saponins. Ivy leaves show convulsive/antispasmodic, anti-inflammatory, antimicrobial, analgesic, anthelmintic and anti-thrombin activity. Not only ivy but also marshmallow and mustard seeds are used for these indications. This study was conducted to evaluate the efficacy and safety of Cough (EMA; European Medicines Agency) granules used for upper respiratory disorders. This clinical trial was conducted on 150 patients, out of which 75received the Cough (EMA) granules and 75received the placebo. The age range of patients was 3 years to above 15 years. The sample paired t-test was applied to evaluate the significant level. Cough (EMA) granules were found effective in the treatment of cough, cold, and flu symptoms. The new treatment Cough (EMA) granules were safe and well tolerated in patient at given specific age group. The study recommends that Cough (EMA) granules can be used effectively in the treatment of upper respiratory tract infection.
subject
0Althaea
1Hedera
2Cough -- Drug Therapy
3Plant Extracts -- Therapeutic Use
4Respiratory Tract Infections -- Drug Therapy
general
030587469
1English
2MEDLINE/PubMed (U.S. National Library of Medicine)
3MEDLINE/PubMed (NLM)
sourceidmedline
recordidmedline30587469
issn
01011601X
11011-601X
rsrctypearticle
creationdate2018
addtitlePakistan journal of pharmaceutical sciences
searchscope
0medline
1nlm_medline
2MEDLINE
scope
0medline
1nlm_medline
2MEDLINE
lsr41201811
citationpf 2617 vol 31 issue 6 (Supplementary
startdate20181101
enddate20181131
lsr30VSR-Enriched:[pqid, galeid, issue, date]
sort
titleThe evaluation ofefficacy and safety of Cough (EMA) granules used for upper respiratory disorders
authorKhan, Muhammad Faizan ; Akram, Muhammad ; Akhter, Naheed ; Mukhtiar, Muhammad ; Zahid, Rabia ; Khan, Fahad Said ; Daniyal, Muhammad ; Tahir, Imtiaz Mahmood ; Ahmed, Khalil ; Sharif, Aamir ; Kausar, Shamaila ; Shah, Syed Muhammad Ali ; Usmanghani, Khan
creationdate20181100
lso0120181100
facets
frbrgroupid9165989501283338943
frbrtype5
newrecords20190702
languageeng
creationdate2018
topic
0Althaea
1Hedera
2Cough–Drug Therapy
3Plant Extracts–Therapeutic Use
4Respiratory Tract Infections–Drug Therapy
collectionMEDLINE/PubMed (NLM)
prefilterarticles
rsrctypearticles
creatorcontrib
0Khan, Muhammad Faizan
1Akram, Muhammad
2Akhter, Naheed
3Mukhtiar, Muhammad
4Zahid, Rabia
5Khan, Fahad Said
6Daniyal, Muhammad
7Tahir, Imtiaz Mahmood
8Ahmed, Khalil
9Sharif, Aamir
10Kausar, Shamaila
11Shah, Syed Muhammad Ali
12Usmanghani, Khan
jtitlePakistan Journal Of Pharmaceutical Sciences
toplevelpeer_reviewed
delivery
delcategoryRemote Search Resource
fulltextfulltext
addata
aulast
0Khan
1Akram
2Akhter
3Mukhtiar
4Zahid
5Daniyal
6Tahir
7Ahmed
8Sharif
9Kausar
10Shah
11Usmanghani
aufirst
0Muhammad Faizan
1Muhammad
2Naheed
3Rabia
4Fahad Said
5Imtiaz Mahmood
6Khalil
7Aamir
8Shamaila
9Syed Muhammad Ali
10Khan
au
0Khan, Muhammad Faizan
1Akram, Muhammad
2Akhter, Naheed
3Mukhtiar, Muhammad
4Zahid, Rabia
5Khan, Fahad Said
6Daniyal, Muhammad
7Tahir, Imtiaz Mahmood
8Ahmed, Khalil
9Sharif, Aamir
10Kausar, Shamaila
11Shah, Syed Muhammad Ali
12Usmanghani, Khan
atitleThe evaluation ofefficacy and safety of Cough (EMA) granules used for upper respiratory disorders
jtitlePakistan journal of pharmaceutical sciences
risdate201811
volume31
issue6
spage2617
pages2617-2622
issn1011-601X
formatjournal
genrearticle
ristypeJOUR
abstractIvy leaf is used for the treatment of respiratory diseases with the intensive mucus formation, respiratory infections, and irritating cough coming from the common cold. Conferring to clinical trials, the efficacy, and tolerability of ivy leaf is good. The main compounds accountable for biological activity are triterpene and saponins. Ivy leaves show convulsive/antispasmodic, anti-inflammatory, antimicrobial, analgesic, anthelmintic and anti-thrombin activity. Not only ivy but also marshmallow and mustard seeds are used for these indications. This study was conducted to evaluate the efficacy and safety of Cough (EMA; European Medicines Agency) granules used for upper respiratory disorders. This clinical trial was conducted on 150 patients, out of which 75received the Cough (EMA) granules and 75received the placebo. The age range of patients was 3 years to above 15 years. The sample paired t-test was applied to evaluate the significant level. Cough (EMA) granules were found effective in the treatment of cough, cold, and flu symptoms. The new treatment Cough (EMA) granules were safe and well tolerated in patient at given specific age group. The study recommends that Cough (EMA) granules can be used effectively in the treatment of upper respiratory tract infection.
pmid30587469
oafree_for_read
date2018-11-01